The Unified Patent Court in Paris sided with Abbott (NYSE:ABT) following a CGM patent infringement claim from Dexcom ...

Tandem Diabetes Care has received authorization of sale by Health Canada, paving the way for in-warranty t:slim X2 insulin pump users to be full compatibility with both the Dexcom G7 and Dexcom G6 ...

9 July 2024 Pan-European court hands down second infringement decision | Revokes patent Europe-wide after counterclaim | ...

In a report released today, Larry Biegelsen from Wells Fargo maintained a Buy rating on Dexcom (DXCM – Research Report), with a price target of ...

DexCom (NASDAQ:DXCM – Get Free Report) had its target price increased by stock analysts at Canaccord Genuity Group from $89.00 to $99.00 in a research report issued to clients and investors on Monday, ...

DexCom faces challenges in 2024 due to competition and missteps, but the long-term outlook for continuous glucose monitors ...

Tandem Diabetes Care announced today that t:slim X2 insulin pump users in Canada can now access full compatibility with ...

DexCom Inc (NASDAQ:DXCM) shares up more than 2% following updated guidelines by the American Diabetes Association (ADA), which now recommend using continuous glucose monitors (CGMs) for some adults ...

The American Diabetes Association has released its annual guidelines and they now include continuous glucose monitor use for non-insulin use, ...

Tandem Diabetes Care, Inc. (Nasdaq: TNDM) and Dexcom, Inc. today announced that following the recent authorization of sale by ...

DexCom, Inc. (DXCM), headquartered in California, is a leading player in the medical devices sector. Valued at a market cap ...

The global blood glucose monitoring market size was US$ 13.95 billion in 2021. The global blood glucose monitoring market is forecast to grow to US$ 27.01 billion by 2030 by registering a compound ...